Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis
2020 · Diabetes Therapy · 62 citations
https://doi.org/10.1007/s13300-020-00980-1